Browse drugs

…ompare the effectiveness and safety of HAIC in combination with lenvatinib and programmed death receptor-1 (PD-1) inhibitors (H+L+P) to th…

…tance exceeding 15% in 24/31 and 18/31 countries, respectively. Amoxicillin remains an exception, with resistance rates under 2% in 14/31 c…

…hree RCTs involving 332 patients were included. The addition of SVCI to PVI significantly reduced AF recurrence compared with PVI al…

… antithrombotics (0.71%, P=0.02), and cardiovascular drugs like beta blockers (0.25%, P=0.03) were observed compared with patients with other…

… opioids in recent years. We evaluated trends in receipt of any prescription opioid during the year among military members in the MHS during 2016–2…

…f which three were identified: L-Glutamic acid (p value=0.038), o-Hydroxyphenylacetic acid (p=0.039), L-Homoserine (p value=0.020). Some of these metaboli…

…gh rates of in-stent occlusions in acute stroke treatments. The CGuard stent is a new-generation hybrid dual-layer stent that has been desig…

…ectrode placement. We developed an intravascular EEG electrode (EP01) as a minimally invasive method, and reported that it is possib…

… adverse events of intensive lipid-lowering treatment including evolocumab and ezetimibe (triple therapy) after endovascular thrombectomy …

…eeClimb70&88/HiPoint88; Hippo072; Millipede088; Cereglide71&92; Ballast088) or in advanced testing phase (Broadway84).Method These platfor…

…ysms and is increasingly applied in acutely ruptured cases. The pEGASUS-HPC, a low-profile stent with an antithrombogenic hydrophilic polym…

…ients (using HAS-BLED score)54.3% switch patients from VKA to a NOAC post-CAS (if on VKA before)69.5% transition to NOAC/VKA monothe…